RT Journal Article SR Electronic T1 Global distribution of Leptospira serovar isolations and detections from animal host species: a systematic review and online database JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.10.03.23296503 DO 10.1101/2023.10.03.23296503 A1 Hagedoorn, Nienke N. A1 Maze, Michael J. A1 Carugati, Manuela A1 Cash-Goldwasser, Shama A1 Allan, Kathryn J. A1 Chen, Kevin A1 Cossic, Brieuc A1 Demeter, Elena A1 Gallagher, Sarah A1 German, Richard A1 Galloway, Renee L. A1 Habuš, Josipa A1 Rubach, Matthew P. A1 Shiokawa, Kanae A1 Sulikhan, Nadezhda A1 Crump, John A. YR 2023 UL http://medrxiv.org/content/early/2023/10/03/2023.10.03.23296503.abstract AB Objectives Leptospira, the spirochaete causing leptospirosis, can be classified into >250 antigenically distinct serovars. Although knowledge of the animal host species and geographic distribution of Leptospira serovars is critical to understand the human and animal epidemiology of leptospirosis, currently data are fragmented. We aimed to systematically review the literature on animal host species and geographic distribution of Leptospira serovars to examine associations between serovars with animal host species and regions, and to identify geographic regions in need of study.Methods Nine library databases were searched from inception through 9 March 2023 using keywords including Leptospira, animal, and a list of serovars. We sought reports of detection of Leptospira, from any animal, characterized by cross agglutinin absorption test, monoclonal antibody typing, serum factor analysis, or pulsed-field gel electrophoresis to identify the serovar.Results We included 409 reports, published from 1927 through 2022, yielding data on 154 Leptospira serovars. The reports included data from 66 (26.5%) of 249 countries. Detections were from 144 animal host species including 135 (93.8%) from the class Mammalia, 5 (3.5%) from Amphibia, 3 (2.1%) from Reptilia, and 1 (0.7%) from Arachnida. Across the animal host species, Leptospira serovars that were detected in the largest number of animal species included Grippotyphosa (n=39), Icterohaemorrhagiae (n=29), Pomona (n=28), Australis (n=25), and Ballum (n=25). Of serovars, 76 were detected in a single animal host species. We created an online database to identify animal host species for each serovar by country.Conclusions We found that many countries have few or no Leptospira serovars detected from animal host species and that many serovars were detected from a single animal species. Our study highlights the importance of efforts to identify animal host species of leptospirosis, especially in places with a high incidence of human leptospirosis. We provide an updated resource for leptospirosis researchers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the joint US National Institutes of Health (NIH:www.nih.gov)-National Science Foundation (NSF:www.nsf.gov) Ecology of Infectious Disease program (R01TW009237) and the Research Councils UK, Department for International Development (UK) and UK Biotechnology and Biological Sciences Research Council (BBSRC:www.bbsrc.ac.uk) (grant numbers BB/J010367/1, BB/L018926, BB/L017679, BB/L018845). MJM received support from University of Otago scholarships: the Prof. Sandy Smith Memorial Scholarship, the Frances G. Cotter Scholarship and the MacGibbon Travel Fellowship. SCG and MPR received support from National Institutes of Health Research Training Grants (R25 TW009337 and R25 TW009343) funded by the Fogarty International Center and the National Institute of Mental Health. KJA received support from the Wellcome Trust (www.wellcome.ac.uk)(096400/Z/11/Z). MPR and JAC received support from a US National Institutes of Health National Institute for Allergy and Infectious grant (R01 AI121378). NNH received support from the EU Horizon 2020 research and innovation programme under the project Vacc-iNTS (grant agreement number 815439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. Upon publication the data will be available in an online database.